p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3
Authors
Keywords
-
Journal
CELL CYCLE
Volume 11, Issue 24, Pages 4579-4588
Publisher
Informa UK Limited
Online
2012-12-12
DOI
10.4161/cc.22852
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced transcriptional activity in the p53 pathway of senescent cells revealed by the MDM2 antagonist nutlin-3
- (2016) Baoying Huang et al. Aging-US
- Decision-making by p53 and mTOR
- (2016) Carl G. Maki Aging-US
- DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
- (2016) Olga V. Leontieva et al. Aging-US
- P53 and aging: A fresh look at an old paradigm
- (2016) Masha V. Poyurovsky et al. Aging-US
- The p53 inducing drug dosage may determine quiescence or senescence
- (2016) David P. Lane et al. Aging-US
- mTOR and its link to the picture of Dorian Gray - re-activation of mTOR promotes aging
- (2016) Józefa Węsierska-Gądek Aging-US
- p53, ROS and senescence in the control of aging
- (2016) Arnaud Vigneron et al. Aging-US
- TP53 and MTOR crosstalk to regulate cellular senescence
- (2016) Lorenzo Galluzzi et al. Aging-US
- The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway
- (2016) Lioubov G. Korotchkina et al. Aging-US
- p53 governs telomere regulation feedback too, via TRF2
- (2016) Izumi Horikawa et al. Aging-US
- Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise
- (2016) Reza Soleimani et al. Aging-US
- miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells
- (2015) Oncotarget
- Novel Insights into the Molecular Mechanisms Governing Mdm2 Ubiquitination and Destruction
- (2015) Oncotarget
- The requirement of p53 for maintaining chromosomal stability during tetraploidization
- (2015) Oncotarget
- The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword
- (2015) Oncotarget
- Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy
- (2015) Oncotarget
- Insights into 4E-BP1 and p53 mediated regulation of accelerated cell senescence
- (2015) Suzan K Chao et al. Oncotarget
- Exploiting p53 Status to Enhance Effectiveness of Chemotherapy by Lowering Associated Toxicity
- (2015) Linda S. Steelman et al. Oncotarget
- Network Modeling of MDM2 Inhibitor-Oxaliplatin Combination Reveals Biological Synergy in wt-p53 solid tumors
- (2015) Asfar S. Azmi et al. Oncotarget
- DNA-PKCS binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death
- (2015) Richard Hill et al. Oncotarget
- The RP-Mdm2-p53 Pathway and Tumorigenesis
- (2015) Paula L. Miliani de Marval et al. Oncotarget
- Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture
- (2015) Pasha Apontes et al. Oncotarget
- Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome
- (2015) Paul M. Neilsen et al. Oncotarget
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
- (2015) William H. Chappell et al. Oncotarget
- Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades
- (2015) James Andrew McCubrey et al. Oncotarget
- Effects of Ectopic Expression of NGAL on Doxorubicin Sensitivity.
- (2015) William H Chappell et al. Oncotarget
- Regulation of p53: a collaboration between Mdm2 and Mdmx
- (2015) Dongsheng Pei et al. Oncotarget
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
- (2015) James Andrew McCubrey et al. Oncotarget
- Inhibition of p53 expression modifies the specificity of chromatin binding by the androgen receptor
- (2015) Natalya V. Guseva et al. Oncotarget
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SPA-1 controls the invasion and metastasis of human prostate cancer
- (2011) Yosuke Shimizu et al. CANCER SCIENCE
- Mutant p53 Gain-of-Function in Cancer
- (2009) M. Oren et al. Cold Spring Harbor Perspectives in Biology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started